The **pHoenix Score (pHx-S)** is a novel diagnostic metric developed to enhance the accuracy of diagnosing **gastroesophageal reflux disease (GERD)** using 24-hour pH monitoring. It addresses limitations of traditional methods like acid exposure time (AET) and the DeMeester score (DMS) by integrating upright and supine acid exposure times, offering a more comprehensive and reliable assessment of GERD.
The **pHoenix Score (pHx-S)** is a novel diagnostic metric developed to enhance the accuracy of diagnosing **gastroesophageal reflux disease (GERD)** using 24-hour pH monitoring. It addresses limitations of traditional methods like acid exposure time (AET) and the DeMeester score (DMS) by integrating upright and supine acid exposure times, offering a more comprehensive and reliable assessment of GERD. Below are the key aspects of the pHoenix Score:
---
### **1. Novel Metric:**
The pHoenix Score combines **upright and supine acid exposure times (AET)** into a single metric. This integration provides a more holistic evaluation of acid reflux patterns across different body positions, improving diagnostic precision compared to AET alone.
---
### **2. Reduced Inconclusive Results:**
One of the major advantages of the pHoenix Score is its ability to significantly reduce inconclusive GERD diagnoses. In studies, the pHx-S reduced inconclusive diagnoses to **4.7% of cases**, which is a **57% reduction** compared to using AET alone. This makes the pHoenix Score particularly valuable in clinical scenarios where traditional methods might leave uncertainty.
---
### **3. High Diagnostic Accuracy:**
The pHoenix Score demonstrates exceptional diagnostic performance:
These metrics are comparable to the established DeMeester score (DMS), underscoring the reliability and robustness of the pHoenix Score in identifying GERD.
---
### **4. Meal Independence:**
Unlike some traditional diagnostic methods that require strict compliance with meal recording, the pHoenix Score's accuracy is **independent of meal periods**. Whether meal periods are included or excluded during the 24-hour pH monitoring, the pHx-S maintains its diagnostic precision. This feature simplifies the process for both patients and clinicians.
---
### **5. Clinical Advantages:**
The pHoenix Score offers several clinical benefits:
---
### **Conclusion:**
The **pHoenix Score (pHx-S)** represents a significant advancement in GERD diagnosis using 24-hour pH monitoring. Its integration of upright and supine AET, high sensitivity and specificity, independence from meal recording, and ability to reduce inconclusive cases make it a valuable tool for clinicians. By addressing the limitations of traditional metrics like AET and DMS, the pHoenix Score simplifies and improves the diagnostic process for GERD.
Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...
Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...
Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...
Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...
Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...
Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.